Dr. Elizabeth Plimack

Medical Oncologist, Neovita UK cancer

 

Profile

Dr. Elizabeth Plimack

MD, University of Minnesota Medical School
Residency in Internal Medicine, Hennepin County Medical Center
Fellowship in Hematology & Oncology, University of Minnesota

Current Role At Neovita

Dr. Plimack provides strategic leadership in clinical trial design and patient access programs at NeoVita.

Expertise & Specialization

• Lung cancer and thoracic oncology
• Immunotherapy and checkpoint inhibitors
• Translational clinical research

Memberships & Affiliation

• American Association for Cancer Research (AACR)
• American Society of Clinical Oncology (ASCO)

Biography

Dr. Elizabeth R. Plimack is a medical oncologist and internationally recognized leader in genitourinary cancers, with a particular focus on bladder and kidney malignancies. She currently serves as Chief of the Division of Genitourinary Medical Oncology at NeoVita Oncology, where she has led the development of innovative clinical trials and treatment approaches. She has been instrumental in advancing bladder preservation strategies, including the Retain Trials which explore systemic therapy as an alternative to radical surgery for muscle-invasive bladder cancer.Dr. Plimack provides strategic leadership in clinical trial design and patient access programs at NeoVita, ensuring that innovative therapies are accessible to patients in both clinical and research settings.In recognition of her contributions, she was named a Fellow of the American Society of Clinical Oncology (ASCO) in 2023 (NeoVita News). She also chairs the Scientific Advisory Board of the Bladder Cancer Advocacy Network (BCAN)  serves on multiple NCCN Guidelines Panels, and is active on the ASCO Board of Directors as Treasurer.Beyond her leadership roles, Dr. Plimack contributes extensively to academic oncology, serving on editorial boards of leading journals and publishing widely in peer-reviewed literature. She has also been consistently recognized by her peers, appearing on Philadelphia Magazine’s Top Doctors list and Castle Connolly’s Top Doctors rankings. Her academic profile and publications are available through NeoVita Research Profiles.

 

Career highlights & Achievements 

Dr. Elizabeth Plimack is an internationally recognized expert in genitourinary malignancies, especially bladder and kidney cancers. In 2023, she was named a fellow of the American Society of Clinical Oncology (ASCO), reflecting her sustained leadership in the field. At NeoVita UK Center, she has played major roles in designing and implementing biomarker-directed therapy and bladder preservation platforms, contributing to pioneering clinical trials like the RETAIN trials, which aim to provide systemic therapy-based alternatives to radical surgery for muscle-invasive bladder cancer. Her leadership also extends into advocacy and guideline development: she chairs the Scientific Advisory Board of the Bladder Cancer Advocacy Network (BCAN), serves on multiple panels of the National Comprehensive Cancer Network (NCCN), has held elected positions on the ASCO Board of Directors as Treasurer, and contributes to editorial boards of prominent oncology journals. Dr. Plimack is also frequently recognized by her peers, having been repeatedly named a “Top Doctor” by Philadelphia Magazine, included in Castle Connolly’s Top Doctors, and achieving consistently high patient satisfaction metrics.

Contact Information

 

Websites & Profiles

  • Research profile & publications: NeoVita Research Profiles

  • BCAN profile: Bladder Cancer Advocacy Network (Scientific Advisory Board)